designer drug offered online vendors cannabimimetic agent structure pharmacological activity published prior commercial availability reported high affinity ki nm receptors ki features groups found previously reported synthetic cannabinoids tetramethylcyclopropane group well substituent information regarding vivo activity published anecdotal reports known psychoactivity humans psychoactive products new zealand containing drug given interim approval psychoactive substances